Myriad Genetics

  • 1
  • 2
  • Next Page

ACLU Asks Supreme Court to Hear Gene Patents Case

By Sarah Roberts, Speech, Privacy and Technology Project at 5:49pm

Today, the ACLU petitioned the Supreme Court to hear our case challenging patents on two human genes related to breast and ovarian cancer.

The case, Association for Molecular Pathology, et al. vs. Myriad Genetics, et al., was filed in 2009 on behalf of medical associations, geneticists, genetic counselors, patients, and breast cancer and women's health groups, which all have been negatively impacted by Myriad Genetics’ patents on the BRCA1 and BRCA2 genes.

Your Genes, Your Rights

By Sandra S. Park, ACLU Women's Rights Project at 4:13pm

This post is part of Mom's Rising's Blog Carnival on women's health and economic rights, held this week to commemorate the anniversaries of the 1920 passage of the 19th Amendment and the 1963 March on Washington.

When you hear about patents on human genes, women's rights might not immediately come to mind. Yet, a woman's right to access medical care, make informed medical decisions, and benefit from scientific research is at the core of this issue.

Who Owns Your Genes? The Case Continues…

By Sandra S. Park, ACLU Women's Rights Project at 8:10am

Today, a divided appellate court upheld patents on two human genes associated with hereditary breast and ovarian cancer. The ruling partially reverses a landmark decision by a federal district court in March 2010 that concluded that human genes cannot be patented. The appellate court did affirm the district court’s invalidation of several claims on methods for comparing two genetic sequences.

Our Genes, Our Rights — To Be Argued Monday

By Sandra S. Park, ACLU Women's Rights Project at 5:15pm

The ACLU was before a federal appeals court today arguing that human genes should not be patented.  Arguing with us was Acting Solicitor General Neal Katyal, who argued that patents on human genes issued by the Patent Office are invalid.

  • 1
  • 2
  • Next Page
Statistics image